2021
DOI: 10.1177/1076029620982374
|View full text |Cite
|
Sign up to set email alerts
|

Device-Induced Hemostatic Disorders in Mechanically Assisted Circulation

Abstract: Mechanically assisted circulation (MAC) sustains the blood circulation in the body of a patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) or on ventricular assistance with a ventricular assist device (VAD) or on extracorporeal membrane oxygenation (ECMO) with a pump-oxygenator system. While MAC provides short-term (days to weeks) support and long-term (months to years) for the heart and/or lungs, the blood is inevitably exposed to non-physiological shear stress (NPSS) due to mechanical pump… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
33
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(34 citation statements)
references
References 170 publications
(220 reference statements)
1
33
0
Order By: Relevance
“…These three options come with their own advantages and disadvantages. The tradeoff for hemodynamic stability in mechanical circulatory support (MCS) is the risk of cannulation, heparinization, and the known effects of non-physiological shear stress and artificial surfaces [ 25 , 26 ]. While sequential OLV avoids these pitfalls, hemodynamic instability may ensue, or there may be severe hypotension following pressure on the heart [ 25 ].…”
Section: Intraoperative Machine Supportmentioning
confidence: 99%
“…These three options come with their own advantages and disadvantages. The tradeoff for hemodynamic stability in mechanical circulatory support (MCS) is the risk of cannulation, heparinization, and the known effects of non-physiological shear stress and artificial surfaces [ 25 , 26 ]. While sequential OLV avoids these pitfalls, hemodynamic instability may ensue, or there may be severe hypotension following pressure on the heart [ 25 ].…”
Section: Intraoperative Machine Supportmentioning
confidence: 99%
“…EVs have been described to be increased in the circulation of LVAD patients [ 16 , 17 , 20 , 21 ]. However, to our knowledge, no study has yet investigated the influence of the LVAD pump itself on EV release.…”
Section: Discussionmentioning
confidence: 99%
“…As a novel biomarker of interest to evaluate the hemocompatibility of LVADs, extracellular vesicles (EVs) are focused on in recent publications [ 16 , 17 ]. EVs are small lipid structures (<1 µm) released by all types of blood cells.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…We hope that the developed approach may find its further application for the assessment of patient-specific thrombotic risk factors in haemodialysis patients with AVFs. Also the approach might be extended to several other clinically valid settings with increased risk of thrombosis (for example, in circulatory assist devices) [ 41 , 42 ].…”
Section: Introductionmentioning
confidence: 99%